top of page
PASSRACGP Logo_white.png

Progress

0%

Cardiovascular

Cardiovascular Disease (CVD) Risk Assessment


Definition:Cardiovascular disease (CVD) encompasses conditions affecting the heart and blood vessels, such as coronary artery disease, heart failure, and stroke. Risk assessment identifies high-risk individuals for early intervention to reduce morbidity and mortality.


Causes/Aetiology:

  • Hypertension: Major contributor to CVD.

  • Dyslipidaemia: High LDL and low HDL cholesterol.

  • Smoking: Increases atherosclerosis risk.

  • Diabetes: Heightens heart disease and stroke risk.

  • Family History: Early-onset CVD in first-degree relatives.

  • Obesity and Inactivity: Contribute to diabetes, hypertension, and dyslipidaemia.


Pathophysiology:CVD results from lifestyle, environmental, and genetic factors leading to atherosclerosis. Plaques in the arteries restrict blood flow, causing heart attack, stroke, and peripheral artery disease.


Symptoms:

  • Chest Pain: Often due to angina or heart attack.

  • Shortness of Breath: Associated with heart failure.

  • Fatigue: Commonly linked to heart disease.

  • Palpitations: Irregular heartbeats signaling potential arrhythmia.

  • Dizziness or Fainting: Indicates poor circulation or arrhythmias.

  • Swelling: Often in legs, related to heart failure.


Differential Diagnosis:

  • Anxiety: Chest pain and palpitations, typically not exertion-related.

  • GERD: Mimics chest pain, usually relieved by antacids.

  • Musculoskeletal Pain: Discomfort often related to posture/activity.

  • Panic Attacks: Palpitations and shortness of breath without exertion.


Investigations:

  • Blood Pressure: Hypertension screening.

  • Lipid Profile: Total cholesterol, LDL, HDL, triglycerides.

  • ECG: Checks arrhythmias, past heart attacks, ischemic changes.

  • Blood Glucose and HbA1c: Diabetes screening.

  • Kidney Function Tests (eGFR, ACR): CKD is a significant CVD risk factor.

  • Cardiac Imaging: Echo or coronary CT scan for heart function and artery assessment.


CVD Risk Assessment Guidelines:

  • Ages 45-79: Routine CVD screening.

  • Diabetes Patients (35-79): Earlier and more frequent assessment.

  • First Nations (30-79): Begin screening from 18-29 based on individual risk.


Automatic High-Risk Categories:

  • Familial Hypercholesterolaemia: Elevated CVD risk.

  • Chronic Kidney Disease (CKD): Moderate-to-severe cases with eGFR <45 or ACR >25 (men) / >35 (women).


Management:

  • Lifestyle Modifications: Weight loss, healthy diet, regular exercise, smoking cessation, limit alcohol.

  • Medications: Statins for cholesterol, antihypertensives for BP, diabetes meds as required, aspirin for high-risk patients with history of CVD events.


Complications:Heart attack, stroke, heart failure, disability, or death.


Prognosis:Early identification and management can significantly reduce CVD complications. Long-term outcomes depend on adherence to treatment and lifestyle modifications.


Notes:

  • Annual Assessment for ATSI Patients: Even low or intermediate-risk individuals.

  • High BP (>160/100 mmHg): Treat regardless of CVD risk.

  • Reclassification: Adjust risk level based on additional factors (e.g., CAC score, CKD, family history, mental health conditions requiring specialist treatment).

Bookmark Failed!

Bookmark Saved!

bottom of page